Friday, March 31, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Takeda
Professor of Hemostasis and Thrombosis
University College London
Clinical Lead
Hematopathology and Blood Transfusion
University College London Hospitals
London, United Kingdom
Professor of Medicine
Division of Hematology
University of Washington
School of Medicine
Director
Washington Center
for Bleeding Disorders
Seattle, Washington
Head
Department of Internal Medicine
Vascular Medicine and Coagulation Disorders Director
Comprehensive Care Hemophilia Treatment Center
and the Hemostasis and Thrombosis Unit
Vivantes Klinikum im Friedrichshain
Berlin, Germany
Professor of Hemostasis and Thrombosis
Hannover Medical School
Hannover, Germany
Professor of Hematology,Bern University Hospital,University of Bern,
Bern, Switzerland
Professor
Division of Hematology
Director
Benign Hematology
Ohio State University
Comprehensive Cancer Center
Columbus, Ohio, United States
Professor
Hematologist, Department of Medicine
Graduate Program Director,
Translational Medicine
Queen's University
Kingston, Ontario, Canada
Steering Committee Member
Disclosure: Rebecca Kruse-Jarres, MD, MPH, has the following relevant financial relationships:
Served as an advisor or consultant for: BioMarin; CRISPR; CSL-Behring; Genentech; Pfizer; Roche
Served as a speaker or a member of a speakers bureau for: Genentech; Takeda
Received grants for clinical research from: Genentech
Steering Committee Member
Disclosure: Robert Klamroth, MD, PhD, has the following relevant financial relationships:
Served as an advisor or consultant for: Bayer; BioMarin; Biotest; CSL Behring; Grifols; Novo Nordisk; Octopharma; Pfizer; Roche; Sanofi; SOBI; Takeda
Served as a speaker or a member of a speakers bureau for: Alexion; Bayer; BioMarin; Biotest; Chugai; CSL Behring; Daiichi Sankyo; Grifols; Novo Nordisk; Octopharma; Pfizer; Roche; Sanofi; SOBI; Takeda
Contracted researcher for: Bayer; BioMarin; Chugai; CSL Behring; Novo Nordisk; Octapharma; Pfizer; Roche; Sanofi; Sobi; Takeda
Steering Committee Member
Disclosure: Andreas Tiede, MD, PhD, has the following relevant financial relationships:
Served as an advisor or consultant for: Bayer; BioMarin; Biotest; Boehringer Ingelheim; Chugai; CSL Behring; Daiichi Sankyo; LEO; Novo Nordisk; Octapharma; Pfizer; Portola; Roche; Sobi; Takeda
Served as a speaker or a member of a speakers bureau for: Bayer; BioMarin; Biotest; Boehringer Ingelheim; Chugai; CSL Behring; Daiichi Sankyo; LEO; Novo Nordisk; Octapharma; Pfizer; Portola; Roche; Sobi; Takeda
Received grants for clinical research from: Biotest; Chugai; CSL Behring; Novo Nordisk; Octapharma; Pfizer; Roche; Sobi; Takeda Contracted researcher for: Novo Nordisk; Octapharma; Roche; Sobi; Takeda
Steering Committee Member
Disclosure: Johanna A. Kremer Hovinga, MD, has the following relevant financial relationships:
Served as an advisor or consultant for: Bayer; Novo Nordisk; Octapharma; Roche; Sanofi; Sobi; Takeda
Served as a speaker or a member of a speakers bureau for: CSL Behring; Novo Nordisk; Roche; Sanofi; Siemens; Takeda
Received grants for clinical research from: Baxalta US; Bayer; CSL Behring; Novo Nordisk; Octapharma; Roche; Sobi; Takeda
Steering Committee Member
Disclosure: Spero Cataland, MD, has no relevant financial relationships.
Steering Committee Member
Disclosure: Marie Scully, MD, has the following relevant financial relationships:
Served as an advisor or consultant for: Alexion; Novartis; Sanofi; Takeda
Served as a speaker or a member of a speakers bureau for: Alexion; Novartis; Octapharma; Sanofi; Takeda
Received grants for clinical research from: Alexion; Shire
